1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors ezetimibe/simvastatin 10/20 mg + placebo, ezetimibe/simvastatin 10/20 mg + MK0524A - Cardiovascular Diseases, Hyperlipidemia | Phase 4 | Withdrawn | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2009-11-01 | 2015-03-24 |
Cardiovascular Diseases (1) · Hyperlipidemias (1)
Dyslipidemias (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Ezetimibe (1) · Ezetimibe, Simvastatin Drug Combination (1) · Simvastatin (1)
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)